| Organism name | Cudrania tricuspidata |
|---|---|
| Genus | Cudrania |
| Family | Moraceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Maclura tricuspidata |
|---|---|
| Linked NCBI taxonomy ID | 210328 |
| Linked level | species |
| Family in NCBI taxonomy | Moraceae |
|---|---|
| ID | 3487 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00036965
|
Cudraxanthone F
|
No. 14 | No. 15 |
|
||||
|
C00038877
|
Cudratricusxanthone K
|
CHEMBL228335
|
No. 14 | No. 15 |
|
|||
|
C00019057
|
Isoerysenegalensein E
/ 5,7,4'-Trihydroxy-6-(2-hydroxy-3-methyl-3-butenyl)-8-prenylisoflavone |
CHEMBL559714
|
No. 14 | No. 15 |
|
|||
|
C00013414
|
Cudraflavone D
/ 2-[2,4-Dihydroxy-5-(3-methyl-2-butenyl)phenyl]-5,7-dihydroxy-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
No. 14 | No. 15 |
|
||||
|
C00013412
|
Cudraflavone C
/ 2',4',5,7-Tetrahydroxy-3,6-bis(3-methyl-2-butenyl)flavone / 2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-3,6-bis(3-methyl-2-butenyl)-4H-1-benzopyran-4-one |
CHEMBL485777
|
No. 14 | No. 15 |
|
|||
|
C00019062
|
Erysenegalensein E
|
CHEMBL557493
|
No. 14 | No. 15 |
|
|||
|
C00009516
|
6,8-Diprenylgenistein
/ 8-(gamma,gamma-Dimethylallyl)wighteone / 5,7,4'-Trihydroxy-6,8-diprenylisoflavone |
CHEMBL494252
|
12 / 14 / 11 | No. 14 | No. 15 |
|
||
|
C00039430
|
Isocudraxanthone K
|
CHEMBL390040
|
No. 18 | No. 15 |
|
|||
|
C00036963
|
Cudraxanthone B
|
No. 18 | No. 15 |
|
||||
|
C00036966
|
Cudraxanthone K
|
No. 18 | No. 15 |
|
||||
|
C00030035
|
Cudraflavone A
|
CHEMBL230558
|
No. 18 | No. 15 |
|
|||
|
C00004053
|
Cycloartocarpesin
/ 8-(2,4-Dihydroxyphenyl)-5-hydroxy-2,2-dimethyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one |
CHEMBL221908
|
2 / 0 / 0 | No. 24 | No. 15 |
|
||
|
C00038874
|
Cudraflavanone B
|
CHEMBL460437
|
No. 28 | No. 14 |
|
|||
|
C00008332
|
Cudraflavanone A
|
CHEMBL220746
|
2 / 0 / 0 | No. 39 |
|
|||
|
C00009945
|
Senegalensin
|
CHEMBL565072
|
No. 47 | No. 15 |
|
|||
|
C00036964
|
Cudraxanthone E
|
No. 47 | No. 15 |
|
||||
|
C00038882
|
Cudraxanthone L
|
CHEMBL197916
|
2 / 0 / 0 | No. 47 | No. 15 |
|
||
|
C00038875
|
Cudratricusxanthone A
|
CHEMBL200640
|
No. 47 | No. 15 |
|
|||
|
C00038876
|
Cudratricusxanthone J
|
CHEMBL395246
|
No. 47 | No. 15 |
|
|||
|
C00047150
|
7,8]isoflavone
/ (+)-5,4'-Dihydroxy-6-(3'-methylbut-2''-enyl)-2'''-(4'''-hydroxy-4'''-methylethyl)-3'''-methoxydihydrofurano-[4''',5''' |
CHEMBL557289
|
No. 47 | No. 15 |
|
|||
|
C00038880
|
Cudraxanthone C
|
CHEMBL200429
|
2 / 0 / 0 | No. 47 | No. 15 |
|
||
|
C00038879
|
Cudratricusxanthone M
|
CHEMBL397206
|
No. 47 | No. 15 |
|
|||
|
C00002554
|
Orobol
/ Santol / Norsantal / 5,7,3',4'-Tetrahydroxyisoflavone |
CHEMBL241609
|
C059811
|
1 / 1 / 8 | No. 71 | No. 15 |
|
|
|
C00038878
|
Cudratricusxanthone L
|
CHEMBL228337
|
No. 425 | No. 15 |
|
|||
|
C00008657
|
Gericudranin E
|
CHEMBL454853
|
No. 1068 |
|
||||
|
C00008658
|
Gericudranin D
|
CHEMBL510170
|
No. 1068 |
|
||||
|
C00047152
|
5,7,4'-Trihydroxy-8-p-hydroxybenzyldihydroflavonol
|
CHEMBL563192
|
No. 1068 |
|
||||
|
C00047151
|
6,7] isoflavone
/ 5,4'-Dihydroxy-8-(3''-methylbut-2''-enyl)-2'''-(4'''-hydroxy-4'''-methylethyl) furano[4''',5''' |
CHEMBL559517
|
No. 3921 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| P35610 | Sterol O-acyltransferase 1 | Enzyme | C00004053 C00008332 C00038880 C00038882 | 0 / 0 |
| O75908 | Sterol O-acyltransferase 2 | Enzyme | C00004053 C00008332 C00038880 C00038882 | 0 / 0 |
| P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00009516 | 0 / 0 |
| P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00002554 | 1 / 8 |
| P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00009516 | 2 / 0 |
| O75496 | Geminin | Unclassified protein | C00009516 | 0 / 0 |
| Q99700 | Ataxin-2 | Unclassified protein | C00009516 | 1 / 1 |
| P04062 | Glucosylceramidase | Enzyme | C00009516 | 6 / 4 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | C00009516 | 0 / 0 |
| Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00009516 | 0 / 0 |
| O75164 | Lysine-specific demethylase 4A | Enzyme | C00009516 | 0 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00009516 | 4 / 3 |
| Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00009516 | 0 / 0 |
| O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00009516 | 1 / 0 |
| P01215 | Glycoprotein hormones alpha chain | Unclassified protein | C00009516 | 0 / 3 |
| OMIM | preferred title | UniProt |
|---|---|---|
| #114500 | Colorectal cancer; crc |
P84022
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #608013 | Gaucher disease, perinatal lethal |
P04062
|
| #230800 | Gaucher disease, type i |
P04062
|
| #230900 | Gaucher disease, type ii |
P04062
|
| #231000 | Gaucher disease, type iii |
P04062
|
| #231005 | Gaucher disease, type iiic |
P04062
|
| #137800 | Glioma susceptibility 1; glm1 |
O75874
|
| #613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
| #211980 | Lung cancer |
P00533
|
| #168600 | Parkinson disease, late-onset; pd |
P04062
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| KEGG | name | UniProt |
|---|---|---|
| H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
| H00017 | Esophageal cancer |
P00533
(related)
|
| H00018 | Gastric cancer |
P00533
(related)
|
| H00022 | Bladder cancer |
P00533
(related)
|
| H00028 | Choriocarcinoma |
P00533
(related)
|
| H00030 | Cervical cancer |
P00533
(related)
|
| H00042 | Glioma |
P00533
(related)
P00533 (marker) |
| H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
| H00081 | Hashimoto's thyroiditis |
P01215
(marker)
|
| H00082 | Graves' disease |
P01215
(marker)
|
| H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P01215
(marker)
|
| H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
| H00126 | Gaucher disease |
P04062
(related)
|
| H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
| H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|